August 26, 2016 11:20 AM ET

Biotechnology

Company Overview of Signal Genetics, Inc.

Executive Profile

Richard A. Bender M.D., F.A.C.P.

Chief Medical Officer, Signal Genetics, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 5 different industries.

See Board Relationships
----

Background

Dr. Richard A. Bender, M.D., F.A.C.P. has been a Chief Medical Officer of Signal Genetics, Inc. since September 14, 2015. Dr. Bender served as Senior Vice President of Medical Affairs for Oncology at Miraca Life Sciences, Inc. since April 5, 2011. Dr. Bender served as Vice President and Chief Medical Officer of Agendia B.V. since April 1, 2008. He served as Chief Medical Officer of Spectrum Pharmaceuticals, Inc. from February 2008 to February 2009 and served as its Senior ...

Corporate Headquarters

5740 Fleet Street
Carlsbad, California 92008

United States

Phone: 760-537-4100
Fax: 760-537-4101

Board Members Memberships

There is no Board Members Memberships data available.

Education

MD
University of California, Los Angeles, School of Medicine
BA
University of California, Santa Barbara

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Mark Christopher Capone Chief Executive Officer, President and Director
Myriad Genetics, Inc.
$933.6K
Peer M. Schatz Chief Executive Officer and Managing Director
Qiagen NV
$1.2M
Douglas M. VanOort Chairman of the Board and Chief Executive Officer
Neogenomics Inc.
$1.1M
Kimberly J. Popovits Chairman of The Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$686.4K
Michael J. Pellini M.D., MBAChief Executive Officer and Director
Foundation Medicine, Inc.
$479.7K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Signal Genetics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.